Sudden Infant Death: Clinical Trials

79 trials for Sudden Infant Death, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

42 completed, 9 terminated, 8 recruiting, 7 active not recruiting. 27 Not applicable, 16 Phase 2, 13 Phase 3, 10 Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable27Completed 18, Not yet recruiting 3, Recruiting 2, Terminated 2, Unknown 2
Phase 216Completed 7, Active not recruiting 4, Terminated 3, Enrolling by invitation 1, Recruiting 1
Phase 313Completed 6, Active not recruiting 4, Terminated 2, Enrolling by invitation 1
Phase 110Completed 5, Terminated 2, Active not recruiting 1, Recruiting 1, Withdrawn 1
Phase 42Completed 2

Follow Sudden Infant Death: new trials by email Literature Review of Sudden Infant Death trials Research Report on Sudden Infant Death

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Social Media and Risk-reduction Training for Preterm Infant Care Practices
Safe Sleep NICU Quality Improvement Campaign, Shared Reading NICU Quality Improvement Campaign, Safe Sleep TodaysNICUBaby videos and messages - Safe Sleep Education, SUID
Not applicableNot yet recruitingUniversity of Massachusetts, Worcester16002027-01-012026-05-13
Supply Induced Demand in Intensive Care Unit: a Retrospective Trial
Intensive Care (ICU), Intensive Care Unit (ICU) Admission
Not yet recruitingSaint Camillus International University of Health Sciences15002026-08-202026-08-17
Infant Safe Sleep in Pediatric Emergency Depratment
Safe Sleep Education, Behavior habit tracking - Infant Safe Sleep Practices, SIDS
Not applicableNot yet recruitingState University of New York at Buffalo2142026-08-172026-08-21
RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome)
RGX-121-3102 - MPS II, Hunter Syndrome (MPS II)
Phase 3Active not recruitingREGENXBIO Inc.22025-11-252026-06-04
The Impact of the Nurse-Led "My Baby is Safe" Educational Program
Education and Counseling, Leaflet - Sudden Infant Death Syndrome, Shaken Baby Syndrome
Not applicableNot yet recruitingAmasya University502025-07-012025-06-26
Incorporation of Safe Sleep Education Into m-Health Technology
Safety in Seconds mobile app: Safe Sleep Education, Safety in Seconds mobile app: Car Seat Safety Education - Sudden Infant Death
Not applicableCompletedJohns Hopkins University1302025-07-012026-09-17
Get Social Media and Risk-Reduction Training
TodaysBaby - Infant Death, Sudden Infant Death
Not applicableRecruitingUniversity of Virginia100002025-05-012025-06-11
The Effect of the Use of Mobile App
Education and Counseling, Standard Care - Sudden Infant Death Syndrome
Not applicableCompletedAmasya University402025-01-012025-07-31
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
whole genome sequencing - Sudden Infant Death, Sudden Unexplained Infant Death
RecruitingNantes University Hospital6502024-08-272026-06-18
JessieHug Feasibility and Usability Assessment
JessieHug - SIDS
Not applicableTerminatedWeill Medical College of Cornell University312024-04-102026-04-27
Training About Sudden Infant Death Syndrome
Training with Sudden Infant Death Syndrome Training Booklet - Sudden Infant Death
Not applicableCompletedOndokuz Mayıs University602024-04-012026-09-22
An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007
tividenofusp alfa - Mucopolysaccharidosis II
Phase 2 / Phase 3Enrolling by invitationDenali Therapeutics Inc.992023-09-202026-10-27
Environmental Exposures and Sudden Unexpected Infant Death
Sudden Unexpected Infant Death, Air Pollution, Pesticides
Active not recruitingNantes University Hospital1002023-09-012024-12-03
Investigation of the Genetic Diseases in Infants With Unknown Cause of Death
Sudden Infant Death
UnknownAnkara University1002023-09-012023-09-29
The Effect of Video-Assisted Sudden Infant Death Syndrome Prevention Training Program and Counseling Practice on Mothers' Knowledge Level and Self-efficacy: Randomized Controlled Study
VASIDS-TP and Counseling Practice - Sudden Infant Death
Not applicableUnknownDilara Aydin Tozlu802023-07-012023-04-21
Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record
ISA-MI, Standard of Care (SOC) - Sudden Infant Death, Sudden Unexplained Infant Death
Not applicableRecruitingJohns Hopkins University3502022-09-302026-07-21
Safety and Efficacy of HMI-203 in ERT-Treated Adults With MPS II
Genetic HMI-203 - Mucopolysaccharidosis II
Phase 1WithdrawnHomology Medicines, Inc2022-09-082023-08-28
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)
tividenofusp alfa, idursulfase - Mucopolysaccharidosis II
Phase 2 / Phase 3Active not recruitingDenali Therapeutics Inc.652022-07-212026-09-09
MPS II Immunophenotyping
MPS II, Mucopolysaccharidosis II
TerminatedDuke University62022-04-012024-09-19
Mucopolysaccharidosis Type II Observational
Observational - Mucopolysaccharidosis II
WithdrawnREGENXBIO Inc.2022-03-012022-10-10

Showing 20 of 79. Sign in to see all of them.

Narrower conditions

Mucopolysaccharidosis II (33)  ·  Lysosomal Storage Diseases (11)  ·  Mucopolysaccharidosis I (8)  ·  Mucopolysaccharidoses (7)  ·  Mucopolysaccharidosis VI (7)  ·  Leukodystrophy, Globoid Cell (6)  ·  Infant Death (5)  ·  Mucopolysaccharidosis III (5)  ·  Stillbirth (5)  ·  alpha-Mannosidosis (5)  ·  Adrenoleukodystrophy (4)  ·  Gaucher Disease (4)  ·  Leukodystrophy, Metachromatic (4)  ·  Perinatal Death (4)

Broader conditions

Death (79)  ·  Death, Sudden (79)  ·  Pathologic Processes (79)  ·  Pathological Conditions, Signs and Symptoms (79)  ·  Infant Death (74)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (39)  ·  Nutritional and Metabolic Diseases (38)  ·  Skin and Connective Tissue Diseases (38)  ·  Carbohydrate Metabolism, Inborn Errors (37)  ·  Connective Tissue Diseases (37)  ·  Genetic Diseases, Inborn (37)  ·  Metabolic Diseases (37)  ·  Mucinoses (37)  ·  Nervous System Diseases (37)  ·  Metabolism, Inborn Errors (36)

Interventions

idursulfase (7)  ·  Standard of Care (3)  ·  Counseling (2)  ·  Educational Status (2)  ·  Alemtuzumab (1)  ·  Autopsy (1)  ·  Blood Specimen Collection (1)  ·  Data Collection (1)  ·  Evaluation Studies as Topic (1)  ·  GAA protein, human (1)  ·  GALNS protein, human (1)  ·  Growth Hormone (1)  ·  Health Promotion (1)  ·  Human Growth Hormone (1)  ·  Hydroxyurea (1)

Sponsors

Shire (7)  ·  REGENXBIO Inc. (6)  ·  Denali Therapeutics Inc. (4)  ·  University of Virginia (3)  ·  Amasya University (2)  ·  Green Cross Corporation (2)  ·  Johns Hopkins University (2)  ·  Nantes University Hospital (2)  ·  Paul Szabolcs (2)  ·  University of Edinburgh (2)  ·  University of Minnesota (2)  ·  AO GENERIUM (1)  ·  Aldagen (1)  ·  Ankara University (1)  ·  Arkansas Children's Hospital Research Institute (1)

Countries

United States (51)  ·  United Kingdom (15)  ·  Canada (12)  ·  Brazil (9)  ·  France (8)  ·  Turkey (Türkiye) (7)  ·  Germany (6)  ·  Italy (6)  ·  Netherlands (6)  ·  Spain (5)  ·  Argentina (4)  ·  Mexico (4)  ·  South Korea (3)  ·  Sweden (3)  ·  Belgium (2)

Top investigators

Rachel Y Moon, MD (4)  ·  Jasper V Been, MD MPH PhD (2)  ·  Paul Szabolcs, MD (2)  ·  Aaron S Kelly, Ph.D. (1)  ·  Alejandro Jenik, M.D. (1)  ·  Alexander Schramm (1)  ·  Amy Elliott, PhD (1)  ·  Andrea C Gielen, ScD, ScM (1)  ·  Andrew M Taylor, MD (1)  ·  Antonio M Dell'Anna, MD (1)  ·  Arndt Rolfs, Prof. Dr. (1)  ·  Ashley Schneider (1)  ·  Barry Solomon, MD, MPH (1)

Results publications

PMID 15324318, PMID 18761215, PMID 18768277, PMID 19282335, PMID 19665645, PMID 19910149, PMID 19948615, PMID 20515965, PMID 20661883, PMID 21150784, PMID 21349673, PMID 21637107, PMID 21740313, PMID 22192497, PMID 22347922, PMID 22867884, PMID 22929184, PMID 22974573, PMID 23497636, PMID 23510062, PMID 23837440, PMID 24368159, PMID 24438163, PMID 24647275, PMID 24670428, PMID 25043483, PMID 25541100, PMID 25902842, PMID 26050535, PMID 26095521, PMID 26303610, PMID 26873528, PMID 27103591, PMID 27114913, PMID 27114914, PMID 27263400, PMID 27470122, PMID 28120730, PMID 28243577, PMID 28374935, PMID 28657663, PMID 28939661, PMID 28983455, PMID 29067842, PMID 29751845, PMID 30337566, PMID 31254631, PMID 32102934, PMID 32634238, PMID 32750127

NIH funding

U54NS065768 (3), 2023 (2), 2004 (1), 2019 (1), K24RR023681 (1), M01RR006022 (1), R01HD064770 (1), R01HD072815 (1), R01HD072821 (1), R01HD080544 (1), R01HD095060 (1), R01HD110568 (1), R01HL143485 (1), R01MD015818 (1)